Verve International, Africa’s leading domestic payments card scheme and token brand, has announced that its cards are now ...

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29 ...

EXCLUSIVE: Academy Award-winning NYC studio Believe Entertainment Group has signed with Verve for representation. The news ...

On Monday, Verve Therapeutics Inc (VERV) stock saw a decline, ending the day at $4.5 which represents a decrease of $-0.29 or -6.05% from the prior close of $4.79. The stock opened at $4.85 and ...

Verve Group SE reports a robust 45% revenue increase and strategic advancements, despite challenges in cost management and gaming segment performance.

Verve Therapeutics, Inc. has a 52-week low of $4.30 and a 52-week high of $19.34. Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 ...

Africa’s domestic payments card scheme and token brand, Verve International has announced that its cards are now accepted on ...

Artificial intelligence, human and cultural business Verve has launched a technology and services platform called Verve Vero.

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29, 2024 ...